Dergiler / Turkish Journal of Hematology / 2019 / Cilt: 36 - Sayı: 3

The Role of the Local Bone Marrow Renin-Angiotensin System in Multiple Myeloma

Multipl Myelomda Lokal Kemik İliği Renin-Anjiyotensin Sisteminin Rolü

Sayfa
178–185
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Patients with severe-diffuse bone marrowinfiltration showed higher bone marrow VEGF, fVIIIrAg, CD34, andAGTR1 mRNA levels when compared to other patients.Conclusion: AGTR1 expression was found positively correlated withplasma β2-microglobulin level and patients with increased AGTR1expression showed increased bone marrow CD34 levels.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Angiotensin II promotes growth and angiogenesis viatype 1 receptors (AGTR1) in certain tumors.
📊
Temel Bulgular & Veri:In this study, we examinethe bone marrow AGTR1 expression in multiple myeloma (MM) andits relationship with the regulation of angiogenesis and prognosticfactors.Materials and Methods: Bone marrow AGTR1 mRNA levels of 39 MMpatients and 15 healthy controls were analyzed with quantitative RTPCR.
💡
Sonuç & Katkı:Patients with severe-diffuse bone marrowinfiltration showed higher bone marrow VEGF, fVIIIrAg, CD34, andAGTR1 mRNA levels when compared to other patients.Conclusion: AGTR1 expression was found positively correlated withplasma β2-microglobulin level and patients with increased AGTR1expression showed increased bone marrow CD34 levels.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: Angiotensin II promotes growth and angiogenesis viatype 1 receptors (AGTR1) in certain tumors. In this study, we examinethe bone marrow AGTR1 expression in multiple myeloma (MM) andits relationship with the regulation of angiogenesis and prognosticfactors.Materials and Methods: Bone marrow AGTR1 mRNA levels of 39 MMpatients and 15 healthy controls were analyzed with quantitative RTPCR. Immunohistochemical staining of the tissue vascular endothelialgrowth factor (VEGF), CD34, and factor VIIIrAg (fVIIIrAg) was used toassess bone marrow angiogenesis.Results: Bone marrow samples of the patients showed increasedVEGF, fVIIIrAg, and CD34 staining and higher AGTR1 expression levelswhen compared to controls. Patients with severe-diffuse bone marrowinfiltration showed higher bone marrow VEGF, fVIIIrAg, CD34, andAGTR1 mRNA levels when compared to other patients.Conclusion: AGTR1 expression was found positively correlated withplasma β2-microglobulin level and patients with increased AGTR1expression showed increased bone marrow CD34 levels.

Abstract

Amaç: Anjiyotensin II, bazı tümörlerde tip 1 reseptörleri (AGTR1) yoluyla bir büyüme promotörü veya anjiyojenik faktör olarak görev yapar. Bu çalışmada, multipl myelomda (MM) kemik iliği AGTR1 ekspresyonunu ve bunun anjiyogenez ve prognostik faktörlerin düzenlenmesi ile ilişkisini incelemekteyiz. Gereç ve Yöntemler: Otuz dokuz MM hastası ve 15 sağlıklı kontrolde, kemik iliği AGTR1 mRNA düzeyleri kantitatif RT-PCR ile analiz edildi. Kemik iliği anjiogenezi, doku vasküler endotel büyüme faktörü (VEGF), CD34 ve faktör VIIIrAg’nın (fVIIIrAg) immünohistokimyasal ölçümü ile değerlendirildi. Bulgular: Hastalar kontrollerle karşılaştırıldığında daha yüksek kemik iliği VEGF, fVIIIrAg, CD34 ve AGTR1 ekspresyon seviyelerine sahipti ve şiddetli yaygın kemik iliği infiltrasyonu olan hastalar diğer hastalara göre daha yüksek kemik iliği VEGF, fVIIIrAg, CD34 ve AGTR1 mRNA seviyeleri gösterdi. Sonuç: AGTR1 ekspresyonu, plazma β2-mikroglobulin seviyesi ile korele bulundu ve artan AGTR1 ekspresyonu olan hastalarda kemik iliği CD34 seviyelerinde artış görüldü.

🔖

Bu Makaleye Atıf Yap

SAKA, B., SAYİTOĞLU, M., İSTEMİHAN, Z., KARAN, M. A., ERTEN, N., DOĞAN, Ö., ÖZBEK, U., GENÇ, S., TAŞÇIOĞLU, C., BEŞIŞIK, S. (2019). The Role of the Local Bone Marrow Renin-Angiotensin System in Multiple Myeloma. Turkish Journal of Hematology, Cilt: 36 - Sayı: 3, 178–185. https://ajindex.com/articles/413398

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Haznedaroglu IC, Tuncer S, Gürsoy M. A local renin-angiotensin system in the bone marrow. Med Hypotheses 1996;46:507-510
  2. Haznedaroglu IC, Oztürk MA. Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system. Int J Biochem Cell Biol 2003;35:867-880
  3. Wulf GG, Jahns-Streubel G, Strutz F, Basenau D, Hüfner M, Buske C, Wörmann B, Hiddemann W. Paraneoplastic hypokalemia in acute myeloid leukemia: a case of renin activity in AML blast cells. Ann Hematol 1996;73:139-141
  4. Wulf GG, Jahns-Streubel G, Nobiling R, Strutz F, Hemmerlein B, Hiddemann W, Wörmann B. Renin in acute myeloid leukaemia blasts. Br J Haematol 1998;100:335-337
  5. Abali H, Haznedaroglu IC, Goker H, Celik I, Ozatli D, Koray Z, Caglar M. Circulating and local bone marrow renin-angiotensin system in leukemic hematopoiesis: preliminary evidences. Hematology 2002;7:75-82
  6. Tamarat R, Silvestre JS, Durie M, Levy BI. Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Lab Invest 2002;82:747-756
  7. Muramatsu M, Katada J, Hayashi L, Majima M. Chymase as a proangiogenic factor. A possible involvement of chymase-angiotensin-dependent pathway in the hamster sponge angiogenesis model. J Biol Chem 2000;275:5545-5552
  8. Lever AF, Hole DJ, Gillis CR, McCallum IR, McInnes GT, MacKinnon PL, Meredith PA, Murray LS, Reid JL, Robertson JW. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 1998;352:179-184
  9. Escobar E, Rodríguez-Reyna TS, Arrieta O, Sotelo J. Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer. Curr Vasc Pharmacol 2004;2:385-399
  10. Egami K, Murohara T, Shimada T, Sasaki K, Shintani S, Sugaya T, Ishii M, Akagi T, Ikeda H, Matsuishi T, Imaizumi T. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 2003;112:67-75
  11. Munshi NC, Wilson C. Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis. Semin Oncol 2001;28:565-569
  12. Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F, Dammacco F. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 1994;87:503-508
  13. Vacca A, Ria R, Ribatti D, Semeraro F, Djonov V, Di Raimondo F, Dammacco F. A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma. Haemato